Imo, the delay in getting a deal/funding for PBT2 has to do with the partial clinical hold in the US. I'm not sure anyone is going to give them cash upfront if there are any questions and or limitations remaining in regards to the extent of research that can be performed with this molecule. I'm hoping Dr. Stamler has opened a dialogue with the FDA and we get an update on that aspect soon
Antibiotic resistance fund aims 2-4 new antibiotics by 2030, page-5
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $886 | 275.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 56368671 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125986200 | 26 |
View Market Depth
| Last trade - 11.34am 30/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |